The applicant is a neuroimmunologist with molecular biology experience and an interest in immune cell growth and differentiation mechanisms. His training as a neuroimmunologist was completed at the Brigham and Women's Hospital (BWH), Boston, MA. He is a member of the BWH Cancer Center. He also holds an appointment as a Neurology Instructor at Harvard Medical School. His interest is now focused on the function of histone deacetylase 3 (HDAC3), a member of a family of genes implicated in leukemia, that he cloned under his own initiative in the sponsor's laboratory. The scientific goal of this proposal is to understand the subcellular pathways implicated in HDAC3 function. Our hypothesis is that HDAC3 is part of an immunoregulatory nuclear molecular complex and its aberrant expression could lead to cell cycle dysregulation and abnormal growth.
The Specific Aims are: 1) generate HDAC3 mutants and chimeras with altered enzymatic or protein-binding activity, 2) identify functional consequences of HDAC3 mutant overexpression on mediation of transcriptional repression of targeted reporter genes, cell cycle progression and differentiation of mammalian cells, and 3) clone and characterize the mouse HDAC3 genomic locus to generate HDAC3-knockout mice for an in vivo analysis of its function. The applicant's training in molecular biology and cell immunology has allowed him to explore the critical regulatory role that HDAC3 plays in cell growth and differentiation. He realizes, however, that in order to answer the next set of questions regarding HDAC3 function, he needs additional training. The Mentored Clinical Scientist Development Award will provide the crucial means for a complementary protein biochemistry and gene knockout technology training period necessary for achieving independence in a cancer research career. The sponsor's laboratory provides an ideal environment to accomplish the aims of this project because of its strong biochemistry and genetics background, the collaborative momentum it has achieved, and its exemplary didactic and ethical curriculum. After completing this project, the applicant will competitively examine the in vivo function of HDAC3 in murine hematologic cells, and its role in malignancies (leukemia/lymphomas) that infiltrate the nervous system.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Clinical Investigator Award (CIA) (K08)
Project #
1K08CA080084-01A1
Application #
2904330
Study Section
Subcommittee G - Education (NCI)
Program Officer
Myrick, Dorkina C
Project Start
1999-07-12
Project End
2004-06-30
Budget Start
1999-07-12
Budget End
2000-06-30
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Villanueva, Raul; Iglesias, Antonio H; Camelo, Sandra et al. (2006) Histone deacetylase 3 represses HTLV-1 tax transcription. Oncol Rep 16:581-5
Gray, Steven G; Dangond, Fernando (2006) Rationale for the use of histone deacetylase inhibitors as a dual therapeutic modality in multiple sclerosis. Epigenetics 1:67-75
Camelo, Sandra; Iglesias, Antonio H; Hwang, Daehee et al. (2005) Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis. J Neuroimmunol 164:10-21
Dangond, Fernando; Hwang, Daehee; Camelo, Sandra et al. (2004) Molecular signature of late-stage human ALS revealed by expression profiling of postmortem spinal cord gray matter. Physiol Genomics 16:229-39
Gray, S G; Iglesias, A H; Teh, B T et al. (2003) Modulation of splicing events in histone deacetylase 3 by various extracellular and signal transduction pathways. Gene Expr 11:13-21
Lizcano, F; Koibuchi, N; Fukuda, H et al. (2001) Cell type-specific roles of histone deacetylase in TR ligand-independent transcriptional repression. Mol Cell Endocrinol 172:13-20
Hsiao, L L; Dangond, F; Yoshida, T et al. (2001) A compendium of gene expression in normal human tissues. Physiol Genomics 7:97-104
Dangond, F; Henriksson, M; Zardo, G et al. (2001) Differential expression of class I HDACs: roles of cell density and cell cycle. Int J Oncol 19:773-7